- Home
- RVPHW vs TOVX Comparison
RVPHW vs TOVX Comparison
Compare RVPHW & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- TOVX
- Stock Information
- Founded
- RVPHW N/A
- TOVX 2001
- Country
- RVPHW United States
- TOVX United States
- Employees
- RVPHW 15
- TOVX N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- RVPHW Health Care
- TOVX Health Care
- Exchange
- RVPHW Nasdaq
- TOVX Nasdaq
- Market Cap
- RVPHW N/A
- TOVX N/A
- IPO Year
- RVPHW 2018
- TOVX 2006
- Fundamental
- Price
- RVPHW $0.12
- TOVX $1.46
- Analyst Decision
- RVPHW
- TOVX
- Analyst Count
- RVPHW 0
- TOVX 0
- Target Price
- RVPHW N/A
- TOVX N/A
- AVG Volume (30 Days)
- RVPHW N/A
- TOVX 4.3M
- Earning Date
- RVPHW N/A
- TOVX 11-11-2024
- Dividend Yield
- RVPHW N/A
- TOVX N/A
- EPS Growth
- RVPHW N/A
- TOVX N/A
- EPS
- RVPHW N/A
- TOVX N/A
- Revenue
- RVPHW N/A
- TOVX N/A
- Revenue This Year
- RVPHW N/A
- TOVX N/A
- Revenue Next Year
- RVPHW N/A
- TOVX N/A
- P/E Ratio
- RVPHW N/A
- TOVX N/A
- Revenue Growth
- RVPHW N/A
- TOVX N/A
- 52 Week Low
- RVPHW N/A
- TOVX $1.24
- 52 Week High
- RVPHW N/A
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- TOVX 34.45
- Support Level
- RVPHW N/A
- TOVX $1.32
- Resistance Level
- RVPHW N/A
- TOVX $1.47
- Average True Range (ATR)
- RVPHW 0.00
- TOVX 0.16
- MACD
- RVPHW 0.00
- TOVX 0.06
- Stochastic Oscillator
- RVPHW 0.00
- TOVX 31.88
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.